Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 28, 2020 17:00 ET | Source: AVITA Medical

AVITA Medical to Present at the J.P. Morgan 39th Annual Healthcare Conference

VALENCIA, Calif. and MELBOURNE, Australia, Dec. 28, 2020 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
December 15, 2020 08:00 ET | Source: AVITA Medical

RECELL® System Data Presented at American Burn Association Fall Regional Burn Conferences

Abstracts Highlighting Clinical and Health Economic Data Reinforce Effectiveness of Treatment with RECELL System More than 10,000 Patients treated with RECELL System globally VALENCIA, Calif. and...
December 01, 2020 08:00 ET | Source: AVITA Medical

AVITA Therapeutics Appoints Kathy McGee as Chief Operating Officer

VALENCIA, Calif, and MELBOURNE, Australia, Dec. 01, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing...
November 18, 2020 16:01 ET | Source: AVITA Medical

AVITA Therapeutics to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference

VALENCIA, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...
November 10, 2020 16:01 ET | Source: AVITA Medical

AVITA Therapeutics Reports First Quarter 2021 Financial Results

VALENCIA, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...
November 10, 2020 08:00 ET | Source: AVITA Medical

AVITA Therapeutics, Inc.: Results of 2020 Annual Meeting of Shareholders

VALENCIA, Calif. and MELBOURNE, Australia, Nov. 10, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company that is developing and...
November 09, 2020 08:00 ET | Source: AVITA Medical

AVITA Therapeutics and the Houston Methodist Research Institute Enter into Collaboration to Explore Novel Approaches for Skin Rejuvenation

Preclinical research will pair AVITA Therapeutics’ Spray-On Skin™ Cells with Houston Methodist Research Institute’s technologies to reverse cellular aging AVITA Therapeutics secures exclusive...
November 05, 2020 22:30 ET | Source: AVITA Medical

AVITA Therapeutics, Inc. Announces Executive Change

VALENCIA, Calif. and MELBOURNE, Australia, Nov. 05, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing...
November 05, 2020 07:46 ET | Source: AVITA Medical

Avita Therapeutics, Inc. Announces Correction of Time for the Adjourned 2020 Annual Stockholder Meeting

VALENCIA, Calif, and MELBOURNE, Australia, Nov. 05, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing...
November 03, 2020 16:01 ET | Source: AVITA Medical

AVITA Therapeutics Announces Date Change for First Quarter 2021 Earnings Release and Conference Call

VALENCIA, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...